David Giraldos
Campus San Francisco Sq
Zaragoza, AR, Spain
Zaragoza, AR, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Flow cytometry evaluation of cytotoxicity exerted by effector immune cells against tumor cells.
Journal: Methods in cell biology
Published: June 11, 2026
NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells ex vivo and in vivo, especially if combined with daratumumab.
Journal: Oncoimmunology
Published: September 25, 2025
A new rapid lipoarabinomannan urine assay for tuberculosis: a two-centre diagnostic accuracy evaluation in outpatients with and without HIV.
Journal: Research square
Published: March 04, 2025
Performance of a next-generation rapid lipoarabinomannan urine assay for tuberculosis in outpatients with and without HIV in South Africa and Uganda: a two-centre diagnostic accuracy study.
Journal: The Lancet. Microbe
Published: February 11, 2025
Microbiota-Derived Short-Chain Fatty Acids Boost Antitumoral Natural Killer Cell Activity.
Journal: Journal of clinical medicine
Published: May 14, 2024
Toll-like receptors: New targets for multiple myeloma treatment?
Journal: Biochemical pharmacology
Published: January 14, 2022
Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma.
Journal: Cells
Published: December 21, 2021
Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients.
Journal: Oncoimmunology
Published: January 18, 2021
Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance.
Journal: Scientific reports
Published: July 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026